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Clinic studies 
report complete 
resolution 
of idiopathic 
chronic urticaria 
in around  
one-third 
of patients 
and partial 
improvement  
in another third.
Evidence summary 
A prospective cohort study of 220 patients from 
an outpatient dermatology center in Amster-
dam investigated the natural course of chronic 
urticaria and angioedema.1 Researchers catego-
rized patients according to subtypes: idiopathic 
urticaria-angioedema, idiopathic urticaria, id-
iopathic angioedema, physical and idiopathic 
urticaria, and physical urticaria only. 
The duration of symptoms at enrollment 
wasn’t reported. Therapy wasn’t controlled 
and was composed of oral antihistamines, 
steroids, and other drugs. 
One year after enrollment, 35% of pa-
tients had complete resolution of symp-
toms. Resolution rates ranged from a high of 
59.6% in patients with idiopathic urticaria- 
angioedema to a low of 16.4% in patients who 
had urticaria with a physical cause. 
A study finds 1-year control  
or improvement in chronic urticaria
Another prospective cohort study from an 
outpatient dermatology center in Brazil 
evaluated 125 patients with chronic urticaria- 
angioedema.2 Participants were predomi-
nantly adults 20 to 40 years of age, with a 
mean duration of symptoms of 45 months. 
Most patients had idiopathic disease 
(78%), but some had parasitic and skin infec-
tions, medication sensitivities, thyroid disease, 
and other problems that could contribute to 
skin hyperreactivity. Therapeutic interventions 
for underlying conditions or angioedema- 
urticaria weren’t controlled or reported. 
One year after presentation, 58.4% of pa-
tients had symptoms “under control,” 31.7% 
were improved, and 8.9% were unchanged. 
One patient’s symptoms worsened. 
Urticaria is less severe 
in patients older than 30 years
A prospective cohort study followed 62 patients 
with urticaria caused by cold from a tertiary re-
ferral center in Greece.3 The mean age at pre-
sentation was 42 years and the mean duration 
of symptoms was 10 years. The study followed 
patients for a mean of 9 years. Therapeutic in-
terventions weren’t controlled or reported. 
Overall, 29% of patients experienced res-
olution of symptoms, 41.9% noted improve-
ment, and 29% experienced worsening of 
symptoms. The mean time to resolution was 
5.6 years. The study also found that chronic 
urticaria was less severe if patients developed 
the condition after 30 years of age.
Worst prognosis found in patients  
with cold-related urticaria
A retrospective cohort study identified 
544 cases of chronic urticaria and angio-
edema in 22 years of records from a tertiary 
referral center in the Netherlands.4 The mean 
age at presentation was 35 years; patients had 
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EvidEncE-basEd answEr
A  the prognosis for chronic urti-  caria in primary care is un-
known; studies in dermatology clinics in 
multiple countries report complete reso-
lution in approximately one-third of pa-
tients with idiopathic chronic urticaria 
over 1 to 5 years and partial improvement 
in another third. Patients younger than 
30 years with more severe symptoms, or 
symptoms with physical causes, fared 
less well (strength of recommendation: 
B, cohort studies).
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Patients who 
had urticaria 
with a physical 
cause had  
the lowest  
resolution rates.
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been symptomatic an average of 5 years. All 
patients were sent a questionnaire to fill out; 
372 questionnaires were returned.
At 5 years after presentation, symptoms 
resolved in 29% of patients; at 10 years, the 
number of resolved cases increased to 44%. 
Patients with cold-related urticaria had the 
worst prognosis.
Zafirlukast has no effect
An RCT with a study group of 137 patients 
(mean age 41 years) compared the effec-
tiveness of zafirlukast vs placebo for treat-
ing chronic urticaria symptoms. Zafirlukast 
showed no significant benefit over placebo; 
symptoms resolved or improved in 41.3% of 
all patients after 12 weeks.5
Recommendations
Habif’s Clinical Dermatology states that 
chronic urticaria: 
•   may last for months or years
•   may be subject to lengthy and often un-
rewarding evaluation 
•   resolves spontaneously in most cases.6  JFP
